An evaluation of recent federal spending on comparative effectiveness research: priorities, gaps, and next steps.
The American Recovery and Reinvestment Act of 2009 included new funding for developing better evidence about health interventions, with a down payment of $1.1 billion for comparative effectiveness research. Our analysis of funds allocated in the legislation found that nearly 90 percent of the $1.1 billion will eventually be spent on two main types of activity: developing and synthesizing comparative effectiveness evidence, and improving the capacity to conduct comparative effectiveness research. Based on our analysis, priorities for the new funding should include greater emphasis on experimental research; evaluation of reforms at the health system level; identification of effects on subgroups of patients; inclusion of understudied groups of patients; and dissemination of results.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- United States
- Health Policy & Services
- Financing, Government
- Federal Government
- Comparative Effectiveness Research
- American Recovery and Reinvestment Act
- 4407 Policy and administration
- 4203 Health services and systems
- 1402 Applied Economics
- 1117 Public Health and Health Services
Citation
Published In
DOI
EISSN
ISSN
Publication Date
Volume
Issue
Start / End Page
Related Subject Headings
- United States
- Health Policy & Services
- Financing, Government
- Federal Government
- Comparative Effectiveness Research
- American Recovery and Reinvestment Act
- 4407 Policy and administration
- 4203 Health services and systems
- 1402 Applied Economics
- 1117 Public Health and Health Services